instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Serious adverse event report Product A and ongoing Atorvastatin use alongside Product A
Dear Pharmacovigilance Team,
I am the Attending Physician at a specialist neurology centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. T... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with Product B implicated only as concomitant
Dear Clinical Safety and Regulatory Affairs,
I am writing as the caregiver for my elderly aunt Emma Castillo to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse reaction report involving Product A and Amoxicillin also suspected by physician
Dear Pharmacovigilance and Risk Management Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Adverse event notification for Product A with Product B not suspected
Dear Global Safety Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 59 year old male patient on Product A for 16 we... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Safety report Product A and physician suspects both Product A and Omeprazole
Good morning,
I am the Head of Pharmacy Services at a Veterans Affairs medical centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A reaction report with ongoing Levothyroxine use alongside Product A
Dear Medical Affairs and Drug Safety,
I am the Consultant Rheumatologist at a large academic medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Suspected adverse event with Product A and Product B excluded as cause
Dear Corporate Drug Safety Department,
I am the Chief of Medicine at an integrated care system and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Serious adverse event report Product A and Product B unchanged during reaction
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my mother Daniel Reynolds to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Hi,
I am the Consultant Neurologist at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under my care.
I wish to re... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event notification for Product A with Product B implicated only as concomitant
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my wife Angela Garcia to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A reaction and ongoing Product B treatment formal notification
Dear Regional Pharmacovigilance Lead,
I am the Consultant Haematologist at a large academic medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Formal adverse event notification Product A with suspected Ibuprofen co-reaction
Dear Drug Safety Department,
I am the Consultant Rheumatologist at a gastroenterology clinic partnership and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A reaction and Lisinopril maintained as background medication formal notification
To Whom It May Concern,
I am writing as the caregiver for my mother Jason Woods to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A suspected reaction with ongoing Product B treatment – formal report
Good morning,
I am writing as the caregiver for my wife Richard Jenkins to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 50 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction report with previous Product B therapy
Dear Drug Safety Department,
I am the Consultant Cardiologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 29 year ol... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected adverse reaction with Levothyroxine also suspected by physician
Dear Pharmacovigilance and Risk Management Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction report with Metformin stable during Product A reaction
Dear Clinical Safety and Regulatory Affairs,
I am the Pharmacy Operations Manager at an immunology and allergy clinic and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with suspected Lisinopril co-reaction – formal report
Dear Drug Safety Department,
I am the Head of Pharmacy Services at a corporate occupational health provider and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Safety report Product A and Product B past use excluded
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 64 year old male patient on Product A for 13 weeks who develop... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with physician suspects both Product A and Omeprazole
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my wife Robert Porter to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with Product A and Amlodipine both implicated
Dear Regional Pharmacovigilance Lead,
I am the Ward Nurse Manager at a clinical research site network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A suspected adverse reaction with Product B stopped months ago
Dear Regional Pharmacovigilance Lead,
I am the Consultant Gastroenterologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Formal adverse event notification Product A with Metformin continued without change
Dear Clinical Safety and Regulatory Affairs,
I am the Chief of Medicine at a pathology and diagnostics consortium and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse event report Product A plus Product B as background therapy
Dear Patient Safety Team,
I am the Medical Director at a Veterans Affairs medical centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Senior Consultant at a rural district hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating phys... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus Product B prior use not relevant
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my sister Nathan Thompson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Urgent adverse event Product A and concomitant Atorvastatin therapy
Dear Patient Safety Team,
I am the Consultant Gastroenterologist at a Veterans Affairs medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A reaction and Product B past use excluded formal notification
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my sister Peter Phillips to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A reaction and historical Product B use formal notification
Dear Regional Pharmacovigilance Lead,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 76 year old female patient on Produc... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A suspected reaction with Product B prior use not relevant – formal report
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 64 year old male pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and Product B taken alongside
Dear Pharmacovigilance Team,
I am the Clinical Nurse Specialist at a metropolitan ambulance service medical liaison office and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse event and Product B not currently administered report
Dear Sir or Madam,
I am the Consultant Pulmonologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 58 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse reaction with Amoxicillin also suspected by physician
Dear Sir or Madam,
I am the Clinical Pharmacist at a dialysis centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adverse event where the t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as contribut... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating phys... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A suspected adverse reaction with Product B as background therapy
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 45 year old female pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Serious adverse event report Product A and Product A and Methotrexate jointly suspected
Dear Pharmacovigilance Team,
I am the Clinical Pharmacist at a private oncology clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Formal adverse event notification Product A with Omeprazole stable during Product A reaction
Dear Corporate Drug Safety Department,
I am the Head of Pharmacy Services at a pharmaceutical benefit manager and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Urgent adverse event Product A and Product B past use excluded
Dear Post-Marketing Surveillance Unit,
I am the Consultant Haematologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and Product B not suspected report
Dear Clinical Safety and Regulatory Affairs,
I am the Chief of Medicine at a residential care home network managing over 400 elderly residents across 5 facilities and I am formally notifying you of an adverse event report requiring pharmacovigilance re... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse reaction report involving Product A and Product B completed course before reaction
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Nephrologist at a group of private outpatient clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to re... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Suspected adverse event with Product A and concomitant Atorvastatin therapy
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 62 year old male patient initia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Urgent adverse event Product A and Omeprazole concomitant medication only
Dear Sir or Madam,
I am the Pharmacy Operations Manager at a pharmaceutical benefit manager and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction and Methotrexate also suspected by physician formal notification
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my sister Henry Anderson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A reaction report with Product B stopped months ago
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my elderly aunt Ryan Kim to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 60 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Pharmacovigilance report Product A with Ibuprofen excluded as causative agent
Dear Medical Affairs and Drug Safety,
I am the Senior Nurse Practitioner at a geriatric medicine consortium and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected reaction with suspected Levothyroxine co-reaction – formal report
Dear Sir or Madam,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Suspected adverse event with Product A and past Product B exposure
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 60 year old male patient on P... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Serious adverse event report Product A and Product B no current exposure
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Gastroenterologist at a clinical research site network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with concurrent Product B use – formal report
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 73 year old male patient started on Product A 6 weeks ago who d... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus ongoing Lisinopril use alongside Product A
Dear Clinical Safety and Regulatory Affairs,
I am the Medical Director at a residential care home network managing over 400 elderly residents across 5 facilities and I am formally notifying you of an adverse event report requiring p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Safety report Product A and Product B completed treatment historically
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 59 year old male patient on Product A for 16 weeks who developed pr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Suspected adverse event with Product A and concomitant Lisinopril therapy
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 67 year old female patient initia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected reaction with Product B concomitant medication – formal report
To Whom It May Concern,
I am the Senior Consultant at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A reaction and Product B excluded as cause formal notification
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 41 year old female patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A adverse reaction with Product B as background therapy
Good morning,
I am the Ward Nurse Manager at a womens health clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 60 year old male pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A suspected reaction with suspected combined effect Product A and Levothyroxine – formal report
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Formal adverse event notification Product A with Product B discontinued prior to event
Dear Adverse Events Reporting Centre,
I am the Consultant Neurologist at a large endocrinology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Urgent adverse event Product A and Omeprazole excluded as causative agent
Good morning,
I am the Senior Nurse Practitioner at a rural district hospital and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 59 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A suspected adverse reaction with dual suspect Product A and Metformin
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medications as ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A reaction report with Product B discontinued prior to event
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 45 year... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A suspected adverse reaction with Product B historical medication only
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife Kimberly Phillips to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient exp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse event report Product A plus Levothyroxine maintained as background medication
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my husband Stephanie Henderson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event report Product A plus physician suspects both Product A and Amlodipine
Dear Post-Marketing Surveillance Unit,
I am the Consultant Cardiologist at a specialist neurology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event report Product A plus ongoing Product B treatment
Dear Pharmacovigilance Team,
I am writing as the caregiver for my father Steven Murphy to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 68 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Pharmacovigilance report Product A with suspected combined effect Product A and Ibuprofen
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my elderly aunt Scott Barnes to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Suspected adverse event with Product A and Product B taken alongside
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 73 year old male patient sta... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A suspected reaction with Product A and Amlodipine jointly suspected – formal report
Dear Patient Safety Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating phy... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Suspected adverse event with Product A and Levothyroxine also suspected by physician
Dear Clinical Safety and Regulatory Affairs,
I am writing as the caregiver for my sister Joyce Nelson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Good morning,
I am the Head of Pharmacy Services at a faith-based hospital system and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adverse event where the... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Safety report Product A and Product B historical exposure documented
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 76 year old fe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Suspected adverse event with Product A and ongoing Levothyroxine use alongside Product A
Dear Patient Safety Team,
I am the Consultant Haematologist at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A suspected adverse reaction with dual drug reaction Product A and Ibuprofen
To Whom It May Concern,
I am the Senior Consultant at a tertiary referral hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
To Whom It May Concern,
I am the Clinical Pharmacist at a community health partnership covering 12 clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Safety report Product A and Product B no longer taken
Dear Post-Marketing Surveillance Unit,
I am the Consultant Nephrologist at a pathology and diagnostics consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Good morning,
I am writing as the caregiver for my sister Betty Phillips to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspect... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Safety report Product A and suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my elderly aunt Jose Young to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the trea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and dual drug reaction Product A and Ibuprofen report
Dear Pharmacovigilance Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A reaction report with Amlodipine stable during Product A reaction
Dear Patient Safety Team,
I am the Consultant Cardiologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A adverse event and Product B completed treatment historically report
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Hepatologist at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction and Ibuprofen continued without change formal notification
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 48 year old female patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am the Clinical Pharmacy Director at a metropolitan ambulance service medical liaison office and I am submitting this adverse event report on behalf of a patient who presented to our pharm... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Pharmacovigilance report Product A with Ibuprofen taken concurrently not suspected
Dear Pharmacovigilance Team,
I am writing as the caregiver for my husband James Torres to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and Product B completed course before reaction
Dear Corporate Drug Safety Department,
I am the Head of Pharmacy Services at a pathology and diagnostics consortium and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse reaction report involving Product A and both Product A and Lisinopril identified as suspect
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Formal adverse event notification Product A with dual drug reaction Product A and Metformin
Dear Sir or Madam,
I am the Head of Pharmacy Services at a group of private outpatient clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to repo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Serious adverse event report Product A and Amlodipine not implicated in adverse event
Dear Sir or Madam,
I am writing as the caregiver for my father Adam Garcia to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 38 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse event and Product B maintained during event report
Dear Pharmacovigilance and Risk Management Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 67 year old female patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Serious adverse event report Product A and Product B completed treatment historically
Dear Patient Safety Team,
I am the Head of Pharmacy Services at a specialist dermatology centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Suspected adverse event with Product A and Product B unchanged during reaction
Dear Sir or Madam,
I am the Chief of Medicine at a mental health trust and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 67 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction report with dual suspect Product A and Metformin
Dear Pharmacovigilance Team,
I am writing as the caregiver for my mother Rebecca Palmer to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and suspected combined effect Product A and Amlodipine
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Pharmacovigilance report Product A with physician suspects both Product A and Amoxicillin
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Cardiologist at a group of private outpatient clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to rep... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Pharmacovigilance report Product A with Product B no current exposure
Dear Global Safety Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 50 year old female patient on Product A for 15 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and Amoxicillin not implicated in adverse event
Dear Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 38 year old male patient o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Urgent adverse event Product A and dual drug reaction Product A and Atorvastatin
Dear Medical Affairs and Drug Safety,
I am the Clinical Nurse Specialist at a residential care home network managing over 400 elderly residents across 5 facilities and I am documenting this adverse event report on behalf of a pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Urgent adverse event Product A and Product B not currently administered
Good morning,
I am the Consultant Pulmonologist at a paediatric outpatient service and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 42 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A suspected adverse reaction with dual suspect Product A and Omeprazole
To Whom It May Concern,
I am the Consultant Dermatologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Safety report Product A and Product B excluded as cause
Dear Pharmacovigilance Team,
I am the Consultant Neurologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 53 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.